02/10/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

02/10/2024

Oct 2, 2024, 08:24 | Blog
Tanja Obradovic: FDA just approved Osimertinib for adult patients with locally advanced, unresectable non-small cell lung cancer
Tanja Obradovic shared a post on LinkedIn: ''FDA just approved Osimertinib (Tagrisso), a third-generation EGFR-directed…
Oct 2, 2024, 08:19 | Blog
Together we Unite4 Cancer - ICPC
ICPC (International Cancer Patient Coalition) shared a post on LinkedIn: ''Thank you for the overwhelming…
Oct 2, 2024, 08:12 | Blog
Hadi Mohamad Abu Rasheed: Advancing Access to beast cancer early detection and treatment in the EMR
Hadi Mohamad Abu Rasheed shared a post on LinkedIn: ''Save the date! Join us in…
Oct 2, 2024, 07:36 | Dialogues
ASCO24 Updates: Xavier Bower on NorthStar Select: Liquid Biopsy Advancements for Cancer Treatment | OncoDaily
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Oct 2, 2024, 06:11 | Immune Oncology,Oncolibrary
Targeted Therapy vs Immunotherapy: Which Is Right for You, Key Differences & Similarities
Targeted therapy vs immunotherapy is a big debate and huge advancement in cancer treatment. Targeted…
Oct 2, 2024, 05:34 | Blog
Narjust Florez and Gladys Rodriguez celebrating all the Latinas In Medicine in cancer research and care
Latinas In Medicine shared a post on X: "Join us Wed at 7pm EDT with…
Oct 2, 2024, 04:50 | Societies
The ASCO International Cancer Research Scholars Program
The ASCO International Cancer Research Scholars Program is a new initiative designed to support early-career…
All: 87 Posts: 81 - 90
Special Coverage